KINSHASA (Reuters) – An Ebola treatment center at the epicenter of the current outbreak in eastern Democratic Republic of Congo has resumed operations after it was closed in response to an attack last week, the Congolese...
Read MoreBy Allison Lampert and Martinne Geller MONTREAL/LONDON (Reuters) – The Court of Appeal of Quebec upheld on Friday the bulk of a 2015 decision that awarded around C$15 billion ($11.29 billion)to smokers in the Canadian...
Read More
By Lisa Rapaport (Reuters Health) – Three in four obese people with diabetes who had a...
Read More
(Reuters) – U.S. health regulators said on Friday a third cancer-causing toxin was found in...
Read More
By Linda Carroll (Reuters Health) – When multiple doctors are on the job, there’s a...
Read More(Reuters) – Endo International Plc said on Friday the U.S. health regulator has decided https://bit.ly/2XGrm1k not to include blood pressure treatment vasopressin in its list of drugs that can be used in compounding, in a...
Read More
By Lisa Rapaport (Reuters Health) – People in Berkeley, California, dramatically cut their...
Read More
By Lisa Rapaport (Reuters Health) – Adults who quit smoking decades ago may have a lower...
Read More
Myocardial infarction (MI) is the most common, acute manifestation of coronary artery disease...
Read More
(This February 28 story has been refiled to use initial caps in paragraph 7 to indicate that...
Read More
High-risk human papilloma virus (HPV; genotypes 16 and 18) has been strongly associated in...
Read More
For the first time in a decade, physical activity guidelines have been updated, featuring new...
Read More
By Karen Lema and Matthias Blamont MANILA/PARIS (Reuters) – The Philippine Department of...
Read More
DAKAR (Reuters) – Medecins Sans Frontieres (MSF) has suspended medical activities at the...
Read More
(Reuters) – Pfizer Inc said on Thursday it received a request for documents as part of a...
Read More(Reuters) – U.S. drug developer ImmunoGen Inc said on Friday its experimental ovarian cancer drug failed to meet the main goal of a late-stage study, driving its shares more than 40 percent lower on Friday. When compared...
Read More
By Dominique Patton BEIJING (Reuters) – Shares in China’s leading pig producers have...
Read More
Here are what the editors at HealthDay consider to be the most important developments in Allergy for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. 2014 to 2017 Saw Improvement in Burnout for […]
Read More
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. ATS Issues Practice Guideline for Pediatric Home Oxygen […]
Read More
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Tumor Control Durable With Pembrolizumab in Merkel Cell […]
Read More
